In the study, Pan02: A murine model of pancreatic cancer, Labcorp researcher Sumithra Urs, PhD investigated tumor responses to radiotherapy, immunomodulation, and combination therapy. See more below and the original research here.
In this video, Prof. Dr. med Bernadette Eberlein presents on using Radiotherapy for Peyronie Disease. This presentation was part of the 2021 clinical symposia, Radiotherapy for Benign Conditions. See the full recording at https://xstrahl.com/symposia-session-2/...
Sheri Barnes of Labcorp presented as part of an AACR webinar series on her research, Focal Radiation Enhances Anti-Tumor Activity and immunomodulation of checkpoint blockade in the GL261-luc Orthotopic Murine Glioma Model. https://youtu.be/AxFF_vBdk4U
This presentation was part of the 2021 clinical symposia, Radiotherapy for Benign Conditions. See Dr. Shaffer's presentation below from the third session, Radiotherapy for Benign Skin Conditions. Presentation Recording: https://vimeo.com/710489972 Presentation Slides:...
This presentation was part of the 2021 clinical symposia, Radiotherapy for Benign Conditions. See Dr. Ramelyte's presentation below from the third session, Radiotherapy for Benign Skin Conditions. Presentation Recording: https://vimeo.com/710490930 Presentation...
Xstrahl recently installed its 100th 3D cabinet irradiator at Duke University, the latest institution to use SARRP for translational radiation research. To mark this important milestone, we wanted to spotlight Duke’s research interests along with highlights from a few...
This presentation was part of the 2021 clinical symposia, Radiotherapy for Benign Conditions. See Dr. Ogawa's presentation below from the second session, Radiotherapy for Hyperproliferative Disorders. Presentation Recording: https://vimeo.com/710491819
In this publication, Analysis of clonogenic growth in vitro, researchers expanded on the clonogenic assay protocol developed by Puck & Marcus. Researchers expanded the protocol to examine clonogenic survival of cancer and nonmalignant cells in response to radio-...
This presentation was part of the 2021 clinical symposia, Radiotherapy for Benign Conditions. See Dr. Steenbakker's presentation below from the second session, Radiotherapy for Hyperproliferative Disorders. Presentation Recording: https://vimeo.com/710492616
Contact Us